Global University Venturing

Repeatome drug developer Rome Therapeutics is based on intellectual property from Massachusetts General Hospital and Icahn School of Medicine at Mount Sinai.

JHU-founded restorative materials technology developer Lifesprout secured $28.5m in a round led by Redmile Group as it looks to move into regenerative medicine.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MSU Foundation will manage the sector-agnostic vehicle, which will invest $100,000 to $250,000 in pre-seed rounds for Michigan-based businesses.

CAS Star has led a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

CAS Shanghai Institutes for Biological Sciences spinout Aptbio secured funding to enhance its mass spectrometry drug screening business.

The Parkinson's disease therapy developer completed a series A round featuring QB3-aligned Mission Bay Capital.

SwanBio, based on research at Harvard Medical School, has secured a $20m extension to bring its series A round to $45m so far, with commitments to increase it to $77m.

Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.